Lexicon Pharmaceuticals (LXRX) PT Lowered to $5 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Goldman Sachs tech conference highlights AI spending outlook
- Dell shares surge on record AI server bookings
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- 'No panic anywhere' may be the problem, BofA strategists warn
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Lexicon Pharmaceuticals (LXRX) PT Lowered to $6 at H.C. Wainwright
November 1, 2024 6:39 AM EDT(Updated - November 1, 2024 6:40 AM EDT)
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Lexicon Pharmaceuticals (NASDAQ: LXRX) to $6.00 (from $10.00) while maintaining a Buy rating.
The analyst commented: "Yesterday, the AdCom for sotagliflozin in T1D+CKD was... More
Lexicon Pharma (LXRX) Halted, News Pending
October 31, 2024 7:01 AM EDTLexicon Pharma (NASDAQ: LXRX) Halted, News Pending
... More